A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures.
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2017
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions
- Sponsors Eisai Inc
- 05 Dec 2017 Results of post hoc analysis of open label extension studies, presented at the 71st Annual Meeting of the American Epilepsy Society.
- 01 Jan 2012 Results published in Acta Neurologica Scandinavica.
- 25 Jul 2007 Status change from recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History